FABP4 and obesity disorder: Researchers also found significant increases in norepinephrine, glucagon, and fatty acid binding protein 4 (FABP4) after consuming diets containing propionate, suggesting that propionate may be a “metabolic disruptor” that increases the risk of diabetes and obesity (Tirosh et al., 2019).